Diabetes mellitus is characterized by hyperglycemia. An abnormally elevated blood glucose level causes oxidative stress and the formation of advanced glycation endproducts (AGEs), which have been closely linked to diabetic complications such as neuropathy, retinopathy and nephropathy. 1, 2) In particular, diabetics are at increased risk for several types of kidney disease, and the predominant cause of end stage renal disease in this disorder is diabetic nephropathy. 3, 4) However, recent clinical trials suggest that there is no effective treatment for diabetic nephropathy.
In particular, diabetics are at increased risk for several types of kidney disease, and the predominant cause of end stage renal disease in this disorder is diabetic nephropathy. 3, 4) However, recent clinical trials suggest that there is no effective treatment for diabetic nephropathy. 5) Therefore, preventions of the occurrence and progression of diabetic nephropathy has become a very important issue. Therefore, great effort has been focused on traditional and herbal medicine without toxic effects to find a novel therapeutic agent for diabetic nephropathy.
Panax ginseng C. A. MEYER is one of the most widely used herbal medicines in the Orient. It has a wide range of pharmacological and physiological actions, such as antiaging, immunoenhancement, antistress and antitumor. [6] [7] [8] In addition, several investigations strongly support the evidence that ginseng root possesses anti-diabetic properties, such as inhibition of intestinal glucose absorption, increase in energy expenditure, improving sensitivity to insulin and stimulation of sugar metabolism, etc. [9] [10] [11] Moreover, ginseng root has been shown in clinical studies to have beneficial effects in diabetic patients. 12, 13) Of the two kinds of ginseng, white ginseng (WG) is airdried ginseng, and red ginseng (RG) is produced by steaming raw ginseng at 98-100°C for 2-3 h. RG is reportedly more pharmacologically active than WG. 14) These improved biological activities of ginsengs result from changes in the chemical constituents that occur during steam treatment. Ginseng saponins, referred to as ginsenosides, are believed to play a pharmacologically important role. Several investigators have reported new ginsenosides from RG that are not usually found in WG. 15) Recently, a method which can enhance the yield of these RG specific components by steaming ginseng at a temperature higher than RG has been developed. 16) This heat-processed ginseng, termed sun ginseng (SG), has been reported to have more potent pharmacological activities, such as vasorelaxation, antioxidant and anti-tumor activities. 17, 18) Furthermore, SG showed stronger peroxynitrite (ONOO Ϫ ) and hydroxyl radical scavenging activities than WG and RG in our previous in vitro study. 19) However, the effects of SG on diabetic rats have not been reported yet, and the enhanced radical scavenging activities of SG are thought to be beneficial against diabetic oxidative damage caused by hyperglycemia.
Therefore, the protective effect of SG against renal damage caused by oxidative stress or the formation of AGEs under diabetes and its molecular biological mechanism were investigated in this study. sine (CML) was kindly provided by Dr. Nagai of Kumamoto University. The other chemicals and reagents used were of high quality and obtained from commercial sources.
Preparation of SG Extract WG (Panax ginseng C. A. MEYER, four-years-old) was purchased from a local ginseng market in Seoul. SG was made by autoclaving WG at 120°C for 3 h by the reported method.
16) The product was pulverized and extracted three times with MeOH under reflux at 70°C for 2 h, and the solvent was evaporated in vacuo to give a MeOH extract with a yield of about 20%, by weight, of the original ginseng powder. The major pharmacologically active components of SG, so far reported, are ginsenoside-Rg 3 , -Rg 5 , -Rk 1 and maltol, and these compounds are absent or exist in comparably small quantities in conventional WG and RG. [19] [20] [21] Animals and Treatment The Guidelines for Animal Experimentation, approved by the University of Toyama, were followed in these experiments. Male Wistar rats (120-130 g) from Japan SLC, Inc. (Hamamatsu, Japan) were used. They were kept in a plastic-bottomed cage under a conventional lighting regimen with a dark night. The room temperature (about 25°C) and humidity (about 60%) were controlled automatically. They were allowed free access to laboratory pellet chow (CLEA Japan Inc., Tokyo, Japan; comprising 24.0% protein, 3.5% lipid and 60.5% carbohydrate) and water. After several days of adaptation, streptozotocin (STZ, Sigma Chemical Co., St. Louis, MO, U.S.A.) dissolved in citrate buffer (10 mM, pH 4.5) was injected intraperitoneally at a dose of 50 mg/kg body weight following overnight fasting. Ten days after the injection, the glucose level of blood from the tail vein was determined and the rats were divided into 3 groups (each group consisted of 8 rats), avoiding any inter-group differences in blood glucose levels. The control group was given water (vehicle), while the other groups were given the SG extract orally at a dose of 50 or 100 mg/kg body weight daily using a stomach tube. After administration for 15 consecutive days, urine was collected from the metabolic cage and blood samples were collected from the abdominal aorta. The serum was separated immediately from the blood samples by centrifugation. Subsequently, the renal arteries of each rat were perfused with ice-cold physiological saline (0.9% NaCl, pH 7.4), and the kidneys were removed, quickly frozen and kept at Ϫ80°C until analysis.
Assays of Serum and Urine Samples Serum glucose, albumin, urea nitrogen and creatinine (Cr) were determined using commercial reagents (Glucose CII-Test Wako and A/G B-Test Wako were obtained from Wako Pure Chemical Industries Ltd., Osaka, Japan; BUN Kainos and CRE-EN Kainos were obtained from Kainos Laboratories Inc., Tokyo, Japan). The serum glycosylated protein level was measured using a modified thiobarbituric acid (TBA) assay of Fluckiger and Winterhalter. 22) Urine component levels were determined as follows: protein by the sulfosalicylic acid method 23) and Cr using a commercial reagent (CRE-EN Kainos obtained from Kainos Laboratories Inc.). Creatinine clearance (CCr) was calculated on the basis of urinary Cr, serum Cr, urine volume and body weight using the following equation: CCr (ml/min/kg body weight)ϭ[urinary Cr (mg/dl)ϫurine volume (ml)/serum Cr (mg/dl)]ϫ[1000/body weight (g)]ϫ [1/1440 (min)].
Determination of Renal AGEs and TBA-Reactive Substance Levels The renal levels of AGEs were determined by the method of Nakayama et al. 24) Minced kidney tissue was delipidated with chloroform and MeOH (2 : 1, v/v) overnight. After washing, the tissue was homogenized with 0.1 M NaOH, followed by centrifugation at 8000 g for 15 min at 4°C. The amounts of AGEs in these alkali-soluble samples were determined by measuring the fluorescence at an emission wavelength of 465 nm and excitation wavelength of 360 nm using a Tecan SPECTRAFluor (Tecan U.K., Goringon-Thames, U.K.). TBA-reactive substance levels of renal mitochondria were determined as follows: mitochondria were prepared from kidney homogenates by differential centrifugation (800 g, 12000 g, respectively) in a refrigerated centrifuge (4°C) according to the methods of Jung and Pergande 25) with slight modifications. Each pellet was resuspended in preparation medium and the concentration of TBA-reactive substance was determined by the method of Uchiyama and Mihara. 26) Protein levels were evaluated by the micro-biuret method 27) with bovine serum albumin (BSA) as the standard.
Electrophoretic Pattern Analysis of Urinary Protein Samples (60 mg) of protein were loaded on to a 10% acrylamide gel and subjected to sodium dodecyl sulfate polyamide gel electrophoresis (SDS-PAGE), and the protein bands were stained for 30 min with Coomassie brilliant blue R 250 in a distilled water-MeOH-acetic acid (4.5 : 5 : 0.5, v/v/v) mixture and destained overnight in 7% acetic acid. The stained polyamide gels were scanned using a densitometer (AE-6911CX, ATTO Corp., Tokyo, Japan).
Western Blotting Renal cortical sections were homogenized with ice-cold lysis buffer (pH 7.5) containing 137 mM NaCl, 20 mM Tris-HCl, 1% Tween-20, 10% glycerol, 1 mM PMS and protease inhibitor mixture DMSO. Samples were then centrifuged at 2000 g for 10 min at 4°C. The protein concentration of tissue was determined using a Bio-Rad protein assay kit and BSA as a standard, and then immunoblotting was carried out. For the determination of NF-kBp65, IkB-a, COX-2, iNOS, 3-NT, RAGE and CML proteins levels in the kidney, 30 mg protein of each sample was electrophoresed through 8 or 12% SDS-PAGE. Separated proteins were electrophoretically transferred to a nitrocellulose membrane, blocked with 5% skim milk solution for 3 h at 4°C and then incubated with primary antibodies overnight at 4°C. After the blots were washed, they were incubated with goat anti-rabbit and/or goat anti-mouse IgG HRP conjugated secondary antibody for 90 min at room temperature. Each antigen-antibody complex was visualized using ECL Western Blotting Detection Reagents (Amersham, New Jersey, U.S.A.) and detected by chemiluminescence with LAS-1000 plus (FUJIFILM, Japan). Band densities were determined by Scion image software (Scion Corporation, Frederick, MD, U.S.A.) and quantified as the ratio to b-actin.
Data Analysis The results for each group are expressed as meanϮS.E. values. The effect on each parameter was examined using one-way analysis of variance. Individual differences between groups were evaluated using Dunnett's test and those at pϽ0.05 were considered significant. Table 1 shows the effects of SG on changes in physico-metabolic symptoms associated with diabetes over the 15-d experimental period. The body weight gain of STZ-induced diabetic rats was significantly lower than that of normal rats. However, there were no significant changes in body weight between diabetic control and SG-treated groups. In addition, the levels of food and water intake and urine excretion were markedly elevated in diabetic control rats. Food intake amounts showed no changes between diabetic control and SG-treated groups. However, water intake and urine excretion levels were significantly reduced by SG administrations. Table 2 shows the effects of SG on general biochemical parameters of serum and urine. Diabetic control rats showed a remarkably higher blood glucose level than normal rats, while the elevated glucose level was significantly reduced in diabetic rats given 100 mg/kg body weight/d of SG. The glycosylated protein level of the control rats was also significantly increased compared to normal rats, but it was significantly decreased by administration of 100 mg/kg body weight/d of SG. In addition, the serum urea nitrogen level increased from 15.0 mg/dl in normal rats to 26.0 mg/dl in diabetic control rats. It was slightly reduced by administration of 50 mg/kg body weight/d of SG. In the case of serum Cr and urinary protein, these levels were no significant changes in diabetic control rats compared to normal rats, but significantly decreased in SG administered groups. However, there were no significant changes in CCr levels among the normal, diabetic control and SG administered groups.
RESULTS

Changes in Physico-Metabolic Symptoms
Biochemical Features of Serum and Urine
Renal AGEs and TBA-Reactive Substance Levels The effects of SG on renal AGEs and TBA-reactive substance levels are shown in Table 3 . The renal AGEs level in diabetic control rats was significantly higher than in normal rats, but it was effectively lowered by SG administrations to an almost normal level. It declined from 0.96 to 0.81 and 0.80 arbitrary units (AU) by the administration of 50 or 100 mg/kg body weight/d of SG, respectively. Similarly, the renal TBA-reactive substance level was significantly elevated under the diabetic condition, but it was dose-dependently reduced from 1.45 to 0.90 or 0.76 nmol/mg protein by administration of 50 or 100 mg/kg body weight/d of SG, respectively.
Electrophoretic Patterns of Proteinuria Figure 1 shows the effects of SG on the proteinuria pattern in STZ-induced diabetic rats. The albumin band is strongly expressed at about 65 kDa in Fig. 1A , and its band intensities are shown in Fig. 1B . The albumin band intensity of diabetic control rats was about 2.5 times higher than that of normal rat, but it was decreased significantly by SG administrations.
Western Blotting The protein expressions related to oxidative stress-induced damage in renal tissue are shown in Fig. 2A . These protein band intensities were corrected by bactin and are shown in Fig. 2B . There were significant increases in NF-kBp65, COX-2 and iNOS expressions in diabetic rats compared to normal rats. The elevated NF-kBp65 and COX-2 levels in the diabetic control group were signifi- cantly decreased by SG administrations. In the case of the iNOS level, it was mildly but significantly reduced in rats administered 100 mg of SG. On the other hand, there were no significant changes in the IkB-a level between normal and diabetic control groups, and it was slightly increased in SG administered groups (Fig. 2B) . Figure 3 shows the 3-NT level of renal cortex tissue and the band intensities, corrected by b-actin. Nitrotyrosine Immunoblotting Control (NIC) in Fig. 3A indicates nitrated BSA (ca. 65 kDa). The 3-NT level of diabetic control rats was about 1.4 times higher than that of normal rats, as shown in Fig. 3B , but it was significantly reduced by SG administrations.
The proteins related to AGEs formation in renal tissue are shown in Fig. 4 . CML accumulation (ca. 50 kDa) and RAGE expression in diabetic control rats were about 1.5 times higher than normal rats. However, the elevated CML level was gently reduced by SG administrations and showed a significant decrease in the group administered 100 mg/kg body weight/d of SG. On the other hand, the elevated RAGE level was significantly reduced by SG administrations in a dose dependent manner to a nearly normal level.
DISCUSSION
Diabetes mellitus is a disorder characterized by hyperglycemia. Hyperglycemia causes protein glycation and considerable pathogenesis of long term complications of diabetes. In particular, oxidative stress and AGEs formation induced by hyperglycemia are known to influence diabetic renal changes and nephropathy. Features of early diabetic renal changes are glomerular hyperfiltration, glomerular and renal hypertrophy, increased urinary albumin excretion, increased basement membrane thickness and mesangial expansion with the accumulation of extracellular matrix proteins such as collagen, fibronectin and laminin. 28) Many attempts have been made to improve the treatment of diabetes. Various kinds of hypoglycemic drugs or insulin are available now for the control of hyperglycemia, but there is no satisfactory therapy in modern medicine without undesirable side effects or contraindications. Considering these problems, herbal medicines have been focused on because of their comparably nontoxic and mild effects. Ginseng, one of the traditionally used anti-diabetic supplements, showed considerable effects in controlling hyperglycemia and obesity. 11) SG, a recently developed heat-processed ginseng, has been reported to have stronger biological activities than conventional WG and RG. [17] [18] [19] [20] [21] However, the renal protective effect of SG in diabetic rats has not been reported yet, and there are very few reports which have attempted to elucidate the effect of ginseng on diabetes from a molecular biological aspect. In this study, the STZ-induced diabetic rat model was used to investigate the effect of SG on renal damage induced by hyperglycemia under diabetes.
The destruction of b-cells and disorder of insulin secretion in the diabetic state causes physico-metabolic abnormalities such as a decrease in body weight gain and increases in food and water intake and urine volume. The diabetic rats induced by STZ in this study also showed these changes. On the other hand, SG administration significantly reduced water intake and urine excretion levels, suggesting that SG would improve the physiological abnormalities under diabetes.
Hyperglycemia, a primary characteristic of diabetes, is mainly attributed to diabetic oxidative stress by several factors. Hyperglycemia leads to the overproduction of free radicals by the nonenzymatic glycation of proteins through Maillard's reaction, and these free radicals exert deleterious effects on the function of b-cells vulnerable to oxidative stress. 29, 30) In addition, hyperglycemia can degrade antioxidant enzyme defences, thereby allowing reactive oxygen species to cause cellular and tissue damage. As shown in Table 2 , the blood glucose levels in diabetic rats were significantly decreased in rats fed SG at a dose of 100 mg. Among the renal function parameters, serum Cr level in diabetic rats was not significantly increased compared to normal rats, but significantly decreased in SG administered groups, which reduced levels were lower than those of normal rats (Table 2) . Our results obtained with SG were similar to the effects of Chinese prescription Hachimi-jio-gan. 31) Both the sulfosalicylic acid method and SDS-PAGE analysis of urine samples also showed that SG administration reduced the abnormally increased urinary protein levels in diabetic rats ( Table 2 , Fig.  1 ). On the other hand, there were no remarkable ameliorations in serum urea nitrogen and CCr levels. It was considered that the administration period, 15 d, was comparably too short to improve these parameters significantly and only early diabetic renal changes occurred, not advanced ones, in this study. Furthermore, the hyperglycemia condition, a chronic metabolic disorder of glucose, results in irreversible tissue damage by the protein glycation reaction, which leads to the formations of glycosylated protein and AGEs. 32, 33) The glycosylated serum protein level was increased in the present diabetic animal model, which implies that it stimulates the oxidation of sugars, enhancing damage to both sugars and proteins in circulation and the vascular wall, continuing and reinforcing the cycle of oxidative stress and damage. In addition, the accumulation of AGEs in the kidney was also observed. Excessive formation and accumulation of AGEs in tissues can alter the structure and function of tissue proteins. In people with diabetes and/or chronic renal failure, AGEs that accumulate in the kidney are responsible for pathological changes including increased kidney weight, glomerular hypertrophy, glomerular basement membrane thickening and progressive albuminuria. 34) Moreover, AGEs stimulate free radical mechanisms and induce membrane peroxidation, which in turn increase membrane permeability. Therefore, AGEs accumulation in the kidney has been regarded as an index of progressive renal damage in diabetic nephropathy. SG decreased the levels of glycosylated serum protein and renal AGEs significantly (Tables 2, 3 ), suggesting that it would inhibit oxidative damage and irreversible renal damage caused by the protein glycation reaction under diabetes.
A significant increase in TBA-reactive substance, an index of endogenous lipid peroxidation, has been shown under diabetic conditions. 35, 36) Therefore, the measurement of TBA-reactive substance is frequently used to determine the level of oxidative stress in diabetic patients. In addition, the increased lipid peroxidation in the kidney implies the level of suscepti- bility to diabetic oxidative stress, leading to diabetic complications. From this view point, prevention of lipid peroxidation resulting from oxidative stress is considered to play a crucial role in protection from disorders associated with diabetes. The administration of SG reduced the renal TBA-reactive substance level significantly and dose-dependently. These results suggest that SG may alleviate oxidative stress associated with diabetic pathological conditions through the inhibition of lipid peroxidation.
Continuing with considerations of hyperglycemia-induced renal function parameters and tissue damage, Western blot analyses concerning protein expressions related to oxidative stress and AGEs formation were performed. NF-kB is normally present in the cytoplasm of eukaryotic cells as an inactive complex with the inhibitory protein, IkB. When cells are exposed to various external stimuli, such as reactive oxygen species or AGEs, IkB undergoes rapid phosphorylation with subsequent ubiquitination, leading to the proteosome mediated degradation of this inhibitor. The functionally active NF-kB exists mainly as a heterodimer consisting of subunits of the Rel family (e.g., Rel A or p65, p50, p52, c-Rel, v-Rel and Rel B) and translocates to the nucleus, where it binds to specific consensus sequences in the promoter or enhancer regions of target genes, thereby altering their expression. 2, 37) In addition, COX-2 and iNOS are known to be involved in the pathogenesis of many chronic diseases associated with oxidative stress. COX-2 and iNOS expressions are known to be significantly enhanced in the kidney of STZ-induced diabetic rats or mice.
5) NF-kB is involved in the regulation of COX-2 and iNOS expressions. As shown in our results, NF-kBp65, COX-2 and iNOS were overexpressed in the diabetic rat kidney, and these overexpressions were concentration-dependently inhibited by SG administration (Fig. 2) . These findings imply that SG inhibits COX-2 and iNOS expressions by the deactivation of NF-kB.
3-NT, a by-product of the reaction between ONOO Ϫ and proteins, is a potential biomarker of reactive-nitrogen species and increases in diabetic renal tissue. [38] [39] [40] The 3-NT level was also significantly ameliorated by SG administrations (Fig. 3) , suggesting that SG alleviates oxidative stress by inhibiting the generation of reactive-nitrogen species such as ONOO Ϫ . CML, a major AGE in human tissues, is known to be a marker of cumulative oxidative stress and is involved in the development of diabetic nephropathy. 41) Moreover, activation of RAGE by CML results in the activation of NF-kB and the production of proinflammatory cytokines. 2, 42) Therefore, renal accumulation of CML and RAGE expression were investigated in this study. These levels in diabetic rats were 1.5 times higher than normal, but they were significantly ameliorated in SG administered groups (Fig. 4) . These findings imply that SG can prevent diabetic nephropathy by inhibiting RAGE activation by AGEs formation.
In summary, our findings strongly suggest that the inhibition of oxidative stress and AGEs formation may improve and prevent diabetes-induced tissue damage and diabetic complications. SG showed a considerable protecting effect against hyperglycemia-induced renal damage such as diabetic nephropathy by inhibiting AGEs formation and oxidative stress. In particular, SG suppresses RAGE activation related to NF-kB activation by inhibiting AGEs formation. SG also protects the kidney against diabetic oxidative stress induced by expressions of COX-2 and iNOS via deactivation of NF-kB. Furthermore, SG alleviates oxidative stress under diabetic conditions through the inhibition of lipid peroxidation and the generation of reactive-nitrogen species such as ONOO Ϫ . However, the comparisons on the effects of WG, RG and SG were not confirmed in this study, and we want to clarify these subjects in a future study.
In conclusion, the present study provides scientific evidence of the preventive and therapeutic potential of SG against renal damage associated with diabetic oxidative stress.
